Legislation introduced to create a new drug safety office at the FDA
AUTOR(ES)
Lenzer, Jeanne
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=557261Documentos Relacionados
- FDA needs more sophisticated approach to drug safety
- New law aims to distance the FDA from the drug industry
- Symposium: 3. Legislation is likely to create more difficulties than it resolves.
- FDA to review “missing” drug company documents
- Journal calls for new system to monitor post-marketing drug safety